Previous studies found that the levels of HRH3 expression was significantly higher in breast cancer tissues compared with benign tissues and activation of HRH3 led to increased proliferation and migration of breast cancer cells [4], and that rs3787429 and rs3787430 were potential genetic markers for predicting the therapeutic effect of risperidone also in Chinese Han population [8]. Here, HRH3 is linked to breast cancer.